Ganesh Rao
YOU?
Author Swipe
View article: CNSC-30. STROKE DRIVES GLIOMA PROGRESSION THROUGH TUMOR-ASSOCIATED ASTROCYTES
CNSC-30. STROKE DRIVES GLIOMA PROGRESSION THROUGH TUMOR-ASSOCIATED ASTROCYTES Open
Ischemic stroke and brain tumors are deadly neurological disorders, with epidemiological studies revealing an increased risk of developing brain tumors in patients with a prior history of stroke. Comparative transcriptomic analysis in huma…
View article: Nuances in the surgical treatment of gangliocytomas of the spinal cord: illustrative cases
Nuances in the surgical treatment of gangliocytomas of the spinal cord: illustrative cases Open
BACKGROUND Intramedullary gangliocytoma, a tumor rarely seen in the spinal cord, presents unique diagnostic and operative challenges. The authors present 2 cases illustrating these complexities. OBSERVATIONS The first patient, a 34-year-ol…
View article: An Integrated Approach to Sustainable Waste Management (Eco-fusion): Energy Recovery, Carbon Sequestration, and Pollution Mitigation
An Integrated Approach to Sustainable Waste Management (Eco-fusion): Energy Recovery, Carbon Sequestration, and Pollution Mitigation Open
This study proposes a comprehensive waste management system that integrates multiple strategies to convert waste into valuable resources while addressing environmental sustainability. The framework encompasses waste-to-energy conversion, r…
View article: Supplementary Data from Tumor Expression of CD83 Reduces Glioma Progression and Is Associated with Reduced Immunosuppression
Supplementary Data from Tumor Expression of CD83 Reduces Glioma Progression and Is Associated with Reduced Immunosuppression Open
Supplemental Figure Legends
View article: Supplementary Table 1 from Tumor Expression of CD83 Reduces Glioma Progression and Is Associated with Reduced Immunosuppression
Supplementary Table 1 from Tumor Expression of CD83 Reduces Glioma Progression and Is Associated with Reduced Immunosuppression Open
Clinical characteristics
View article: Supplementary Figure 3 from Tumor Expression of CD83 Reduces Glioma Progression and Is Associated with Reduced Immunosuppression
Supplementary Figure 3 from Tumor Expression of CD83 Reduces Glioma Progression and Is Associated with Reduced Immunosuppression Open
Supplementary Figure 3.
View article: Supplementary Table 2 from Tumor Expression of CD83 Reduces Glioma Progression and Is Associated with Reduced Immunosuppression
Supplementary Table 2 from Tumor Expression of CD83 Reduces Glioma Progression and Is Associated with Reduced Immunosuppression Open
DEG Analysis
View article: Supplementary Figure 2 from Tumor Expression of CD83 Reduces Glioma Progression and Is Associated with Reduced Immunosuppression
Supplementary Figure 2 from Tumor Expression of CD83 Reduces Glioma Progression and Is Associated with Reduced Immunosuppression Open
Supplementary figure 2.
View article: Supplementary Figure 1. from Tumor Expression of CD83 Reduces Glioma Progression and Is Associated with Reduced Immunosuppression
Supplementary Figure 1. from Tumor Expression of CD83 Reduces Glioma Progression and Is Associated with Reduced Immunosuppression Open
Supplementary Figure 1
View article: Supplementary Table 1 from Tumor Expression of CD83 Reduces Glioma Progression and Is Associated with Reduced Immunosuppression
Supplementary Table 1 from Tumor Expression of CD83 Reduces Glioma Progression and Is Associated with Reduced Immunosuppression Open
Clinical characteristics
View article: Supplementary Data from Tumor Expression of CD83 Reduces Glioma Progression and Is Associated with Reduced Immunosuppression
Supplementary Data from Tumor Expression of CD83 Reduces Glioma Progression and Is Associated with Reduced Immunosuppression Open
Supplemental Figure Legends
View article: Supplementary Figure 1. from Tumor Expression of CD83 Reduces Glioma Progression and Is Associated with Reduced Immunosuppression
Supplementary Figure 1. from Tumor Expression of CD83 Reduces Glioma Progression and Is Associated with Reduced Immunosuppression Open
Supplementary Figure 1
View article: Supplementary Figure 2 from Tumor Expression of CD83 Reduces Glioma Progression and Is Associated with Reduced Immunosuppression
Supplementary Figure 2 from Tumor Expression of CD83 Reduces Glioma Progression and Is Associated with Reduced Immunosuppression Open
Supplementary figure 2.
View article: Supplementary Table 2 from Tumor Expression of CD83 Reduces Glioma Progression and Is Associated with Reduced Immunosuppression
Supplementary Table 2 from Tumor Expression of CD83 Reduces Glioma Progression and Is Associated with Reduced Immunosuppression Open
DEG Analysis
View article: Supplementary Figure 3 from Tumor Expression of CD83 Reduces Glioma Progression and Is Associated with Reduced Immunosuppression
Supplementary Figure 3 from Tumor Expression of CD83 Reduces Glioma Progression and Is Associated with Reduced Immunosuppression Open
Supplementary Figure 3.
View article: Fractalkine inhibition improves survival and reduces tumor immune cell infiltration in orthotopic murine glioma models
Fractalkine inhibition improves survival and reduces tumor immune cell infiltration in orthotopic murine glioma models Open
View article: Laser Interstitial Thermal Therapy for Brain Tumors: a Prospective Multicenter Analysis of 787 Patients from the LAANTERN Study
Laser Interstitial Thermal Therapy for Brain Tumors: a Prospective Multicenter Analysis of 787 Patients from the LAANTERN Study Open
View article: Figure 4 from Tumor Expression of CD83 Reduces Glioma Progression and Is Associated with Reduced Immunosuppression
Figure 4 from Tumor Expression of CD83 Reduces Glioma Progression and Is Associated with Reduced Immunosuppression Open
Tumoral CD83 influences expression of T-cell exhaustion markers. Immunofluorescence for CD8 and CD3 in pB-IUE control, CD83OE, and Cd83KO tumors (A). Increased number of CD3 and Cd8 T cells in CD83KO…
View article: Data from Tumor Expression of CD83 Reduces Glioma Progression and Is Associated with Reduced Immunosuppression
Data from Tumor Expression of CD83 Reduces Glioma Progression and Is Associated with Reduced Immunosuppression Open
Malignant glioma, the most lethal form of brain cancer, presents with an immunosuppressive microenvironment that obstructs tumor cell clearance and hampers immunotherapeutic interventions. Despite advancements in characterizing cellular an…
View article: Supplementary Figure 1. from Tumor Expression of CD83 Reduces Glioma Progression and Is Associated with Reduced Immunosuppression
Supplementary Figure 1. from Tumor Expression of CD83 Reduces Glioma Progression and Is Associated with Reduced Immunosuppression Open
Supplementary Figure 1
View article: Supplementary Figure 3 from Tumor Expression of CD83 Reduces Glioma Progression and Is Associated with Reduced Immunosuppression
Supplementary Figure 3 from Tumor Expression of CD83 Reduces Glioma Progression and Is Associated with Reduced Immunosuppression Open
Supplementary Figure 3.
View article: Supplementary Figure 2 from Tumor Expression of CD83 Reduces Glioma Progression and Is Associated with Reduced Immunosuppression
Supplementary Figure 2 from Tumor Expression of CD83 Reduces Glioma Progression and Is Associated with Reduced Immunosuppression Open
Supplementary figure 2.
View article: Supplementary Table 1 from Tumor Expression of CD83 Reduces Glioma Progression and Is Associated with Reduced Immunosuppression
Supplementary Table 1 from Tumor Expression of CD83 Reduces Glioma Progression and Is Associated with Reduced Immunosuppression Open
Clinical characteristics
View article: Supplementary Data from Tumor Expression of CD83 Reduces Glioma Progression and Is Associated with Reduced Immunosuppression
Supplementary Data from Tumor Expression of CD83 Reduces Glioma Progression and Is Associated with Reduced Immunosuppression Open
Supplemental Figure Legends
View article: Figure 2 from Tumor Expression of CD83 Reduces Glioma Progression and Is Associated with Reduced Immunosuppression
Figure 2 from Tumor Expression of CD83 Reduces Glioma Progression and Is Associated with Reduced Immunosuppression Open
CD83 influences tumor growth in the pB-IUE system. Kaplan–Meier survival curve of pB-IUE tumors control (n = 17, Med OS = 102 days), CD83KO (n = 20, Med OS = 94 days), and CD83OE (n = 16, Med OS =…
View article: Figure 1 from Tumor Expression of CD83 Reduces Glioma Progression and Is Associated with Reduced Immunosuppression
Figure 1 from Tumor Expression of CD83 Reduces Glioma Progression and Is Associated with Reduced Immunosuppression Open
Antigen presenting–like tumor cells express Cd83 in human and mouse glioma. Expression of GO:0002291: T-cell activation via T-cell receptor contact with antigen bound to MHC molecule on APC and GO:0002468: dendritic cell antigen processing…
View article: Figure 5 from Tumor Expression of CD83 Reduces Glioma Progression and Is Associated with Reduced Immunosuppression
Figure 5 from Tumor Expression of CD83 Reduces Glioma Progression and Is Associated with Reduced Immunosuppression Open
ALTs are sufficient to activate CD8+ T cells and act via cytokine release. In vitro tumor cells cocultured with isolated naïve CD8+ T cells (A). Multispectral imaging and flow cytometry for cocultured na…
View article: Supplementary Table 2 from Tumor Expression of CD83 Reduces Glioma Progression and Is Associated with Reduced Immunosuppression
Supplementary Table 2 from Tumor Expression of CD83 Reduces Glioma Progression and Is Associated with Reduced Immunosuppression Open
DEG Analysis
View article: Figure 6 from Tumor Expression of CD83 Reduces Glioma Progression and Is Associated with Reduced Immunosuppression
Figure 6 from Tumor Expression of CD83 Reduces Glioma Progression and Is Associated with Reduced Immunosuppression Open
ALTs alter the myeloid compartment of the tumor immune microenvironment. Immunofluorescence for Cd11b in pB-IUE control, CD83OE, and Cd83KO tumors (A and B; one-way ANOVA P value < 0.0001, Tukey M…
View article: Figure 3 from Tumor Expression of CD83 Reduces Glioma Progression and Is Associated with Reduced Immunosuppression
Figure 3 from Tumor Expression of CD83 Reduces Glioma Progression and Is Associated with Reduced Immunosuppression Open
CD83 gene signature related to tumor survival, reduced immunosuppressive response signatures, and enhanced antitumor response gene signatures. Expression of CD83 in scRNA-seq from pB-IUE CD83OE compared with control pB-IUE tumors (A…